Advantice Health, LLC

Advantice Health, LLC, based in the US, specializes in developing and marketing an array of skin care products designed to enhance skin health across various concerns and demographics. Founded in 2019 and headquartered in Bridgewater, US, Advantice Health, LLC is focused on producing innovative skin care solutions. The company has executed 2 deals to date, with its most recent acquisition occurring on April 1, 2022, when TA Associates acquired Advantice Health from RoundTable Healthcare Partners and Signet Healthcare Partners for an undisclosed amount. Kristin Recchiuti serves as the CEO.

Advantice Health specializes in developing and marketing diverse skin care products aimed at promoting skin health and wellness for various skin types, concerns, and age groups. Their core product offerings include well-known brands such as AmLactin®, Kerasal®, Dermoplast®, New Skin®, Domeboro®, Triple Paste®, and Emtrix®. These products are designed to address specific skin issues, such as dryness, diaper rash, and nail health, by employing science-backed formulations that offer effective solutions. Advantice's products are distributed primarily in North America, Europe, and select international markets, ensuring accessibility for a broad customer base that includes consumers seeking effective self-care solutions for their skin health.

The company’s commitment to innovation and quality has established its brands as trusted choices among both healthcare professionals and consumers. In the most recent year, Advantice Health reported revenue of SEK 49,910,000. The revenue structure is derived from direct-to-consumer sales, retail partnerships, and wholesale distribution channels. Transactions are facilitated through various storefronts, including pharmacies, supermarkets, and online platforms.

The company’s pricing model is designed to be competitive within the skincare market, appealing to a wide range of consumers, with flagship products such as AmLactin® and Kerasal® marketed at price points catering to both budget-conscious consumers and those seeking premium solutions for their skin care needs. Advantice Health is looking to leverage recent funding for future growth, focusing on designing and launching new products aimed at expanding its market reach. The company intends to target new geographic regions, specifically expanding its presence in Europe and Asia by 2024. The funding from the latest BUYOUT round, involving SEK 1,431,000,000, will support these initiatives and enhance product development efforts.